Cartilage tumours range from benign lesions, such as enchondromas and osteochondromas, to malignant chondrosarcoma. Cytogenetic studies and mouse models are beginning to identify genes and signalling pathways that have roles in tumour progression and potential new therapeutic approaches.
- Judith V. M. G. Bovée
- Pancras C. W. Hogendoorn
- Benjamin A. Alman
